Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Standard BioTools Inc. LAB
$1.77
-$0.01 (-0.56%)
На 18:05, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
125472755.00000000
-
week52high
2.69
-
week52low
0.92
-
Revenue
97948000
-
P/E TTM
-1
-
Beta
1.54705800
-
EPS
-2.28000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Caligan Partners LP | D | 8576799 | 2868037 | 29 дек 2022 г. |
| Davis Jeremy Steven | A | 250000 | 250000 | 20 дек 2022 г. |
| JOG VIKRAM | A | 200000 | 200000 | 20 дек 2022 г. |
| JOG VIKRAM | D | 2238 | 2237 | 21 ноя 2022 г. |
| JOG VIKRAM | D | 11954 | 2391 | 21 ноя 2022 г. |
| JOG VIKRAM | D | 31306 | 3131 | 21 ноя 2022 г. |
| JOG VIKRAM | D | 171904 | 2681 | 21 ноя 2022 г. |
| JOG VIKRAM | A | 174585 | 2237 | 21 ноя 2022 г. |
| JOG VIKRAM | A | 172348 | 2391 | 21 ноя 2022 г. |
| JOG VIKRAM | A | 169957 | 3131 | 21 ноя 2022 г. |
Новостная лента
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results
GlobeNewsWire
31 янв 2023 г. в 08:30
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will report fourth quarter and full year 2022 financial results on Tuesday, February 14, 2023, after the close of the market.
Standard BioTools Inc. (LAB) Q3 2022 Earnings Call Transcript
Seeking Alpha
08 ноя 2022 г. в 22:10
Standard BioTools Inc. (NASDAQ:LAB ) Q3 2022 Results Conference Call November 8, 2022 5:00 PM ET Company Participants Peter DeNardo - Investor Relations Michael Egholm - Chief Executive Officer and President Vikram Jog - Chief Financial Officer Operator Hello, and welcome to the Standard BioTools Inc. Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
Standard BioTools Announces Conference Call and Webcast of Third Quarter 2022 Financial Results
GlobeNewsWire
25 окт 2022 г. в 08:30
SOUTH SAN FRANCISCO, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announced that it will report third quarter 2022 financial results on Tuesday, November 8, 2022, after the close of the market.
Standard BioTools Inc. (LAB) CEO Michael Egholm on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
08 авг 2022 г. в 21:30
Standard BioTools Inc. (NASDAQ:LAB ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Peter DeNardo – Investor Relations Michael Egholm – Chief Executive Officer and President Vikram Jog – Chief Financial Officer Conference Call Participants Operator Hello, and welcome to the Standard BioTools Incorporated Second Quarter 2022 Financial Results Conference Call. As a reminder, this conference is being recorded.
Best Penny Stocks To Buy In August According To Insiders, 1 Bet Over $2 Million
PennyStocks
08 авг 2022 г. в 09:11
Penny stocks to buy according to insiders. The post Best Penny Stocks To Buy In August According To Insiders, 1 Bet Over $2 Million appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.